Cart
sales@molnova.com
Solcitinib
CAS No. 1206163-45-2
Solcitinib( GSK-2586184 | GLPG-0778 )
Catalog No. M10753 CAS No. 1206163-45-2
A potent, selective JAK1 inhibitor for the treatment of psoriasis, lupus, and ulcerative colitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 49 | In Stock |
|
| 25MG | 87 | In Stock |
|
| 50MG | 111 | In Stock |
|
| 100MG | 183 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSolcitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective JAK1 inhibitor for the treatment of psoriasis, lupus, and ulcerative colitis.
-
DescriptionA potent, selective JAK1 inhibitor for the treatment of psoriasis, lupus, and ulcerative colitis.Psoriasis Phase 2 Clinical(In Vitro):Solcitinib is an orally active, competitive, potent, selective JAK1 inhibitor, with an IC50 of 9.8 nM, and 11-, 55- and 23-fold selectivity over JAK2, JAK3 and TYK2, respectively. Solcitinib is used in the research of moderate-to-severe plaque-type psoriasis.
-
In VitroSolcitinib is an orally active, competitive, potent, selective JAK1 inhibitor, with an IC50 of 9.8 nM, and 11-, 55- and 23-fold selectivity over JAK2, JAK3 and TYK2, respectively. Solcitinib is used in the research of moderate-to-severe plaque-type psoriasis.
-
In Vivo——
-
SynonymsGSK-2586184 | GLPG-0778
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK1
-
Research AreaInflammation/Immunology
-
IndicationPsoriasis
Chemical Information
-
CAS Number1206163-45-2
-
Formula Weight389.4503
-
Molecular FormulaC22H23N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20 mg/mL
-
SMILESCC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)C
-
Chemical NameCyclopropanecarboxamide, N-[5-[4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
WHI-P97 HCl 211555-0...
WHI-P97 HCl is a potent and selective JAK-3 inhibitor.?WHI-P97 had an estimated Ki value of 0.09 microM from modeling studies and a measured IC50 value of 2.5 microM in EGFR kinase inhibition assays.?WHI-P97 effectively inhibited the in vitro invasiveness of EGFR-positive human cancer cells in a concentration-dependent manner.
-
Lorpucitinib
Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
-
PF-06263276
PF-06263276 (PF06263276, PF 6263276) is a potent, selective pan JAK inhibitor with IC50 of 2.2, 23.1, 59.9 and 29.7 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
